Drug Profile
F 992
Latest Information Update: 24 Sep 2002
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class
- Mechanism of Action Vasopressin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes insipidus; Urinary incontinence
Most Recent Events
- 24 Sep 2002 Discontinued - Clinical-Phase-Unknown for Diabetes insipidus in Sweden (IV-infusion)
- 24 Sep 2002 Discontinued - Clinical-Phase-Unknown for Urinary incontinence in Sweden (IV-infusion)
- 13 Jun 2000 Investigation in Diabetes insipidus in Sweden (IV-infusion)